BlackRock Investment Management, LLC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 26 filers reported holding CASI PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$4,0000.0%3,3750.0%0.00%
Q3 2016$4,000
+33.3%
3,375
+20.4%
0.00%
Q2 2016$3,0000.0%2,8020.0%0.00%
Q1 2016$3,0000.0%2,8020.0%0.00%
Q4 2015$3,0000.0%2,8020.0%0.00%
Q3 2015$3,000
-40.0%
2,8020.0%0.00%
Q2 2015$5,0000.0%2,802
-14.5%
0.00%
Q1 2015$5,000
+25.0%
3,2760.0%0.00%
Q4 2014$4,000
-33.3%
3,2760.0%0.00%
Q3 2014$6,0003,2760.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders